Search by Drug Name or NDC
NDC 24201-0002-01 Levothyroxine Sodium 100 ug/mL Details
Levothyroxine Sodium 100 ug/mL
Levothyroxine Sodium is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LEVOTHYROXINE SODIUM.
Product Information
| NDC | 24201-0002 |
|---|---|
| Product ID | 24201-002_6405fdb8-edd0-4057-a50f-5562cf3c216f |
| Associated GPIs | |
| GCN Sequence Number | 082296 |
| GCN Sequence Number Description | levothyroxine sodium VIAL 100 MCG/ML INTRAVEN |
| HIC3 | P3A |
| HIC3 Description | THYROID HORMONES |
| GCN | 49672 |
| HICL Sequence Number | 002849 |
| HICL Sequence Number Description | LEVOTHYROXINE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Levothyroxine Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LEVOTHYROXINE SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | ug/mL |
| Substance Name | LEVOTHYROXINE SODIUM |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Thyroxine [CS], l-Thyroxine [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214253 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24201-0002-01 (24201000201)
| NDC Package Code | 24201-002-01 |
|---|---|
| Billing NDC | 24201000201 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (24201-002-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |